On the other hand, India has always maintained that its IPR regime is in compliance with the global rules including that of the World Trade...

India and the US had seemingly found a common ground at the Trade Policy Forum on aspects of trade secrets protection, copyright enforcemen...

Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug O...

On April 30, the US has brought out the Special 301 report, an annual review of the global state of IPR protection and enforcement.

Amazon has officially been granted a patent for its brilliant idea to take photos on a white background by US Patent and Trademark Office.

In a major blow to Swiss pharma giant Novartis, the SC earlier this month had rejected its plea for a patent on cancer drug Glivec.

India’s strong stance on minor drug innovations could reverberate in national parliaments and courthouses of the developed world.

For patenting of frivolous patents, unjustified patents, India is taking a very-very strong stand on that issue which will only help patien...

The government on Tuesday cautioned the domestic pharmaceutical industry against attempts by global giants to "harass" them through their "...

MNC durgmakers on Wednesday hit back at their domestic counterparts over frivolous patent issue and said even the local firms are engaged i...

India's Patents Act is globally appreciated, but the authorities here are flouting it themselves.

RA Mashelkar, who chaired the panel that recommended that incremental developments be encouraged by the Indian patent regime, says acceptan...

Swedish government backs India in patent fight against pharma-major Novartis.

The controversial Mashelkar Committee report, which said India will violate WTO agreements if it restricts patents only to new chemical ent...

The government is unlikely to give the Technical Expert Group on patent law - headed by former CSIR DG RA Mashelkar - more time to re-visit...

The fight between India’s globally competent generic drugmakers and the R&D-intensive Big Pharma in the West, who are being increasingly ch...

A high-level panel headed by Council of Scientific and Industrial Research (CSIR) director-general RA Mashelkar has told the government tha...